EZZ Life Sciences (EZZ) Chair Glenn Cross discusses impressive FY23 results in TV interview

30 August 2023 Glenn completed a successful live TV interview.

EZZ Life Sciences (EZZ) Chair Glenn Cross discusses impressive FY23 results, highlighting a 176% net profit increase to nearly $4 million and a 147% revenue surge. The growth is attributed to significant sales in China, Australia, and New Zealand.

Fast forward to 18:55 for Glenn’s interview section: https://ausbiz.com.au/media/mma-offshores-growth-momentum-ezz-going-strong-?videoId=31352